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INTRODUCTION: Leiomyosarcoma of the small bowel is an extremely rare form of gastrointestinal malig-
nancy. Small bowel tumours are usually asymptomatic at the early stages, and difﬁcult to visualise by
upper and lower endoscopy.
PRESENTATION OF CASE: An 83-year-old gentleman presented in surgical outpatient clinic with chronic
anaemia, abdominal discomfort and a single episode of malaena. Initial OGD and colonoscopy were both
unremarkable. Subsequent CT revealed a mass in the right iliac fossa of likely small bowel origin, leading
to an urgent laparotomy and resection with primary anastomosis. Histopathology showed a high grade
leiomyosarcoma with no signs of metastasis and conﬁrmatory immunological staining. Post-surgery
follow up remains unremarkable.
DISCUSSION: Leiomyosarcomas of the small bowel are extremely rare entities, particularly following the
advent of robust immunohistological diagnostic methods allowing differentiation from GISTs. As small
bowel tumours are often not visualised by upper and lower endoscopy, further investigations to visualise
the small bowel are crucial, generally in the form of magnetic resonance enterography, CT colonography
or wireless capsule endoscopy.
CONCLUSION: The treatment of such tumours remains predominantly centred around surgical resection,
and prognosis is dependent on tumour size and histological staging.
. Pub
he CC© 2014 The Authors
access article under t
. Introduction
Tumours of the small bowel account for less than 5% of all gas-
rointestinalmalignancies.1 Of these, themajority arehistologically
lassed as carcinoid and adenocarcinomas, with sarcomas rank-
ng 5th (∼1.2%).2 Leiomyosarcoma is the most common sarcoma,
ut remains very scarce; with only 26 reported cases of primary
mall bowel leiomyosarcoma following robust immunohistologi-
al techniques.3,4 Small bowel tumours are usually asymptomatic
t the early stages, and difﬁcult to visualise by upper and lower
ndoscopy.5 Consequently, they often present late with poor prog-
osis. In this report, we give the account of an extremely rare case
f leiomyosarcoma of the small bowel presenting in an 83-year-
ld gentleman with chronic anaemia and ominous GI symptoms
ut unremarkable initial examination and investigations.∗ Corresponding author at: Department of Surgery, East Sussex Healthcare Trust,
onquest Hospital, The Ridge, St. Leonards-on-sea, East Sussex, England TN37 7RD,
K. Tel.: +44 1424 755255.
E-mail address: imelda.donnellan@esht.nhs.uk (I.M. Donnellan).
ttp://dx.doi.org/10.1016/j.ijscr.2014.11.009
210-2612/© 2014 The Authors. Published by Elsevier Ltd. on behalf of Surgical Associate
http://creativecommons.org/licenses/by-nc-nd/3.0/).lished by Elsevier Ltd. on behalf of Surgical Associates Ltd. This is an open
BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
2. Presentation of case
An 83-year-old gentleman was referred to the colorectal out-
patient clinic following the discovery of chronic anaemia with a
haemoglobin level of 95g/L, mean corpuscular volume of 85.7 fL,
ferritin of 20mg/L, and normal vitamin B12 and folate levels;
this was carried out under the two weeks urgent referral scheme
for suspected malignancy. Further questioning revealed a single
episode of malaena, some lower abdominal discomfort and a slight
change in bowel habit. He was known to have diverticular dis-
ease, hypertension and ischaemic heart disease, having undergone
a coronary artery bypass graft a few years before. His medications
included aspirin, atorvastatin and a variety of antihypertensive
agents.
On initial examination, he appeared generally well with an
unremarkable abdominal examination. At this point he was trans-
fused 3 units of red cells as the haemoglobin level declined
further to 80g/L; outpatient appointments for oesophago-gastro-
duodenoscopy (OGD) and colonoscopy were arranged.
Both the OGD and colonoscopy gave no clues as to the source
of anaemia; therefore a computed tomography (CT) of the chest,
abdomen and pelvis was carried out (Figs. 1 and 2). The post con-
trast images demonstrate a lobulated, heterogeneously enhancing
soft tissue mass in the right iliac fossa, likely small bowel in origin,
s Ltd. This is an open access article under the CC BY-NC-ND license
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plinary meeting, with histological results conﬁrmed at a regional
tertiary centre. Regular outpatient follow up remains unremark-
able.igs. 1 and 2. Coronal (1) and axial (2) CT post contrast images demonstrating a lob
owel origin. No evidence overt small bowel obstruction, lymph node involvement
ith no overt obstruction, lymph node involvement or free ﬂuid.
o metastases were detected.
An urgent laparotomywas performed, resulting in the resection
f a small bowel mass and its surrounding tissue with primary
nastomosis. The operation was without complication and post-
perative management was uneventful.
Gross analysis showed a large polypoidal tumour measuring
7mm×55mm×30mminvading into the serosa. Themicroscopic
ppearances are those of a leiomyosarcoma Trojani grade 3. A
lear resection margin of 150mm was achieved, with 10 lymph
odes recovered that showed no evidence of metastasis. His-
ological examination showed a submucosal malignant spindle
ell tumour extending into the mucosa and muscularis propria.
umour cells were arranged in a fascicular growth pattern and
ad cigar-shaped nuclei with multiple abnormal mitotic ﬁgures.
mmunohistochemical stains demonstrated positive reactions for
mooth muscle markers including smooth muscle actin (SMA),
yosin, H-caldesmon and desmin. They were negative for CD34
vascular marker as well as haematopoietic progenitor cell antigen
nd stromal cells marker), tyrosine kinase c-kit (CD117) receptor,
nd DOG1, which is usually expressed on the plasma membrane of
astrointestinal stromal tumours (GIST). The proliferation marker
i-67 was variable, approximately 30% in the most active areas
Figs. 3–5)., heterogeneously enhancing soft tissue mass in the right iliac fossa, of likely small
e ﬂuid.
This case was discussed at the local lower GI multidisci-Fig. 3. Sub-mucosal spindle cell tumour inﬁltrating the muscularis mucosae (H&E
stain).
CASE REPORT – O
J. Luis et al. / International Journal of Sur
Fig. 4. The tumour is arranged in fascicles of spindle cells with “Cigar shaped”,
atypical nuclei (H&E stain).
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aig. 5. Large bizarre nuclei andmultiple abnormal mitoses indicative of high-grade
eiomyosarcoma (H&E stain).
. Discussion and conclusion
The incidence of small bowel tumours is 22.7 cases per million,
ith sarcomas accounting for only 1.2% of these.1 Leiomyosarco-
as of the small bowel are therefore extremely rare entities, to the
xtent that the World Health Organisation can provide no mean-
ngful data on demographic or clinical features as a result. Only 26
ocumented cases of small bowel leiomyosarcomaswere identiﬁed
ollowing the advent of its robust differentiation from gastroin-
estinal stromal tumours (GISTs), illustrating the importance of
eporting such cases.3
The diagnosis of small bowel tumours can prove difﬁcult, as
he presentation can be delayed until metastases are present.5 Fur-
hermore, traditional management of ominous symptoms such as
eight loss, constipation and rectal bleeding consists of OGD and
olonoscopy in the ﬁrst instance.6 Small bowel tumours are eas-
ly missed by both modalities, and further imaging is therefore
arranted. Currently, magnetic resonance enterography (MRE), CT
olonography (CTC) and wireless capsule endoscopy (WCE) have
ll been shown to be effective in reaching the diagnosis.7 CTC
nd MRE are able to detect mucosal changes, whilst offering goodPEN ACCESS
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sensitivity to anymetastatic changes,8,9 aswell as informationwith
regard to anymetastases.WCEon theotherhand is superior in visu-
alising small superﬁcial lesions.10 Positron emission tomography
may provide additional utility in detecting metastatic disease,11
however it is not in widespread usage.
Despite advances in imaging, the differentiation between
benign and malignant tumours remains extremely difﬁcult pre-
operatively. The aetiology ofmany cases does not become apparent
until after deﬁnitive resection, the case presented here being a
prime example. Histologically, leiomyosarcomas are differentiated
from GISTs by the lack of CD117 (c-KIT), DOG1 and CD34 as well as
presenceof smoothmuscle actin (SMA)anddesmin.3,12 The tumour
canbegradedusing theTrojani13 or French14 systems for soft tissue
sarcomas, denoting its aggression.
The treatment of all small bowel tumours remains centred
around radical surgical resection.5 However, given the proportion
of cases with late presentations, metastases are an unfortunately
common ﬁnding. Whilst adjuvant chemotherapy agents are in use
for GISTs12 and uterine15 leiomyosarcomas, their uses have not
been proven in the case of small bowel disease.
Tumour size and histological staging are independent progno-
stic factors for 5yeardisease-speciﬁc survival (DSS) inpatientswith
small bowel sarcomas; these appear to be more favourable than
small bowel adenocarcinomas.16 However, the overall prognosis
remains poor.
In summary, leiomyosarcoma in the small bowel is a rare
ﬁnding; the management relies on accurate diagnosis and a
predominantly surgical approach. Given the relatively inaccessi-
ble location of the small intestine to both upper and lower GI
endoscopy, this case highlights the importance of further imaging
in the form of MRE, CT colonography or WCE when faced with a
differential diagnosis of small bowel malignancy.
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Key learning points
1. Leiomyosarcomas of the small bowel can be differentiated from gastrointestinal stromal tumours by immunohisto-
chemical methods.
2. Following normal upper and lower endoscopies, the management of patients with high suspicion of gastrointestinal
malignancy should include urgent second line investigations such as CT colonography, MR enterography or wireless
capsule endoscopy in order to detect small bowel tumours.
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